EP3116897
Pólýmyxín-afleiður og notkun þeirra í samsettri meðferð ásamt mismunandi sýklalyfjum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.3.2015EP published:
2.3.2022EP application number:
15715172.1
EP translation filed:
12.4.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
10.3.2035Expiry date:
10.3.2027Next due date:
31.3.2027
Title in English:
POLYMYXIN DERIVATIVES AND THEIR USE IN COMBINATION THERAPY TOGETHER WITH DIFFERENT ANTIBIOTICSLanguage of the patent:
English
Timeline
Today
11.3.2015EP application
2.3.2022EP Publication
12.4.2022Translation submitted
15.5.2022Registration published
10.3.2027Expires
Owner
Name:
Spero Therapeutics, Inc.Address:
675 Massachusetts Avenue 14th Floor, Cambridge, Massachusetts 02139, US
Inventor
Name:
BROWN, PamelaAddress:
Reading Berkshire RG1 9LS, GB
Name:
DAWSON, MichaelAddress:
Reading Berkshire RG1 9LS, GB
Name:
SIMONOVIC, MonaAddress:
Reading Berkshire RG1 9LS, GB
Name:
BOAKES, StevenAddress:
Reading Berkshire RG1 9LS, GB
Name:
DUPERCHY, EstherAddress:
Reading Berkshire RG1 9LS, GB
Name:
STANWAY, Steven JamesAddress:
Ongar Essex CM5 0GS, GB
Name:
WILSON, AntoinetteAddress:
Ongar Essex CM5 0GS, GB
Name:
MOSS, Stephen FrederickAddress:
Ongar Essex CM5 0GS, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201404301Date:
11.3.2014Country:
GB
Number:
201421019Date:
26.11.2014Country:
GB
Classification
Categories:
C07K 7/62, A61K 38/12
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 11.4.2022
Expires: 10.3.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.2.2023
Expires: 10.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.2.2024
Expires: 10.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 29.1.2025
Expires: 10.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.3.2026
Expires: 10.3.2027
Payer: Árnason Faktor ehf.